369 related articles for article (PubMed ID: 32276135)
1. Redox cycling of copper by coumarin-di(2-picolyl)amine hybrid molecule leads to ROS-mediated modulation of redox scavengers, DNA damage and cell death in diethylnitrosamine induced hepatocellular carcinoma.
Khan S; Zafar A; Naseem I
Bioorg Chem; 2020 Jun; 99():103818. PubMed ID: 32276135
[TBL] [Abstract][Full Text] [Related]
2. Copper-redox cycling by coumarin-di(2-picolyl)amine hybrid molecule leads to ROS-mediated DNA damage and apoptosis: A mechanism for cancer chemoprevention.
Khan S; Zafar A; Naseem I
Chem Biol Interact; 2018 Jun; 290():64-76. PubMed ID: 29803612
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel coumarin nucleus-based DPA drug-like molecular entity: In vitro DNA/Cu(II) binding, DNA cleavage and pro-oxidant mechanism for anticancer action.
Khan S; Malla AM; Zafar A; Naseem I
PLoS One; 2017; 12(8):e0181783. PubMed ID: 28763458
[TBL] [Abstract][Full Text] [Related]
4. Calcitriol-copper interaction leads to non enzymatic, reactive oxygen species mediated DNA breakage and modulation of cellular redox scavengers in hepatocellular carcinoma.
Rizvi A; Farhan M; Naseem I; Hadi SM
Apoptosis; 2016 Sep; 21(9):997-1007. PubMed ID: 27343126
[TBL] [Abstract][Full Text] [Related]
5. Targeting increased copper levels in diethylnitrosamine induced hepatocellular carcinoma cells in rats by epigallocatechin-3-gallate.
Farhan M; Rizvi A; Naseem I; Hadi SM; Ahmad A
Tumour Biol; 2015 Nov; 36(11):8861-7. PubMed ID: 26069106
[TBL] [Abstract][Full Text] [Related]
6. Interaction of C20-substituted derivative of pregnenolone acetate with copper (II) leads to ROS generation, DNA cleavage and apoptosis in cervical cancer cells: Therapeutic potential of copper chelation for cancer treatment.
Zafar A; Singh S; Ahmad S; Khan S; Imran Siddiqi M; Naseem I
Bioorg Chem; 2019 Jun; 87():276-290. PubMed ID: 30908970
[TBL] [Abstract][Full Text] [Related]
7. Cu(II)-coumestrol interaction leads to ROS-mediated DNA damage and cell death: a putative mechanism for anticancer activity.
Zafar A; Singh S; Naseem I
J Nutr Biochem; 2016 Jul; 33():15-27. PubMed ID: 27260464
[TBL] [Abstract][Full Text] [Related]
8. Glutamate release inhibitor, Riluzole, inhibited proliferation of human hepatocellular carcinoma cells by elevated ROS production.
Seol HS; Lee SE; Song JS; Lee HY; Park S; Kim I; Singh SR; Chang S; Jang SJ
Cancer Lett; 2016 Nov; 382(2):157-165. PubMed ID: 27612558
[TBL] [Abstract][Full Text] [Related]
9. Selective Toxicity of Apigenin on Cancerous Hepatocytes by Directly Targeting their Mitochondria.
Seydi E; Rasekh HR; Salimi A; Mohsenifar Z; Pourahmad J
Anticancer Agents Med Chem; 2016; 16(12):1576-1586. PubMed ID: 27109019
[TBL] [Abstract][Full Text] [Related]
10. Potential Chemopreventive Role of Boldine Against Hepatocellular Carcinoma via Modulation of Cell Cycle Proteins in Rat Model.
Subramaniam N; Kannan P; Sundaram J; Mari A; Velli SK; Salam S; Krishnan P; Balaraman G; Thiruvengadam D
Anticancer Agents Med Chem; 2021; 21(18):2546-2552. PubMed ID: 33535961
[TBL] [Abstract][Full Text] [Related]
11. TPP-related mitochondrial targeting copper (II) complex induces p53-dependent apoptosis in hepatoma cells through ROS-mediated activation of Drp1.
Shao J; Li M; Guo Z; Jin C; Zhang F; Ou C; Xie Y; Tan S; Wang Z; Zheng S; Wang X
Cell Commun Signal; 2019 Nov; 17(1):149. PubMed ID: 31744518
[TBL] [Abstract][Full Text] [Related]
12. Redox cycling of endogenous copper by ferulic acid leads to cellular DNA breakage and consequent cell death: A putative cancer chemotherapy mechanism.
Sarwar T; Zafaryab M; Husain MA; Ishqi HM; Rehman SU; Rizvi MM; Tabish M
Toxicol Appl Pharmacol; 2015 Dec; 289(2):251-61. PubMed ID: 26415834
[TBL] [Abstract][Full Text] [Related]
13. Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: A potential new treatment for hepatocellular carcinoma.
Gong K; Li W
Free Radic Biol Med; 2011 Dec; 51(12):2259-71. PubMed ID: 22011623
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel oxidative stress induced cell death by Sorafenib and oleanolic acid in human hepatocellular carcinoma cells.
Lange M; Abhari BA; Hinrichs TM; Fulda S; Liese J
Biochem Pharmacol; 2016 Oct; 118():9-17. PubMed ID: 27544320
[TBL] [Abstract][Full Text] [Related]
15. Nelumbo nucifera leaf extract treatment attenuated preneoplastic lesions and oxidative stress in the livers of diethylnitrosamine-treated rats.
Horng CT; Huang CW; Yang MY; Chen TH; Chang YC; Wang CJ
Environ Toxicol; 2017 Nov; 32(11):2327-2340. PubMed ID: 28804948
[TBL] [Abstract][Full Text] [Related]
16. Anti-Cancer Effects of Citalopram on Hepatocellular Carcinoma Cells Occur via Cytochrome C Release and the Activation of NF-kB.
Ahmadian E; Eftekhari A; Babaei H; Nayebi AM; Eghbal MA
Anticancer Agents Med Chem; 2017 Nov; 17(11):1570-1577. PubMed ID: 28356024
[TBL] [Abstract][Full Text] [Related]
17. Anti-cancer effects of Ajwa dates (Phoenix dactylifera L.) in diethylnitrosamine induced hepatocellular carcinoma in Wistar rats.
Khan F; Khan TJ; Kalamegam G; Pushparaj PN; Chaudhary A; Abuzenadah A; Kumosani T; Barbour E; Al-Qahtani M
BMC Complement Altern Med; 2017 Aug; 17(1):418. PubMed ID: 28830415
[TBL] [Abstract][Full Text] [Related]
18. Sorafenib-induced hepatocellular carcinoma cell death depends on reactive oxygen species production in vitro and in vivo.
Coriat R; Nicco C; Chéreau C; Mir O; Alexandre J; Ropert S; Weill B; Chaussade S; Goldwasser F; Batteux F
Mol Cancer Ther; 2012 Oct; 11(10):2284-93. PubMed ID: 22902857
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of gold(III) Schiff base complexes for the treatment of hepatocellular carcinoma through attenuating TrxR activity.
Bian M; Wang X; Sun Y; Liu W
Eur J Med Chem; 2020 May; 193():112234. PubMed ID: 32213395
[TBL] [Abstract][Full Text] [Related]
20. Berberine and S allyl cysteine mediated amelioration of DEN+CCl4 induced hepatocarcinoma.
Sengupta D; Chowdhury KD; Sarkar A; Paul S; Sadhukhan GC
Biochim Biophys Acta; 2014 Jan; 1840(1):219-44. PubMed ID: 23999088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
